InsiderInsights Daily Ratings Report: July 25, 2022
InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process
Tabula Rasa HealthCare is engaged in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to support medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company delivers its solutions through technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and reminder packaging services. The company's personalized medication risk management services can be based on its MRM Matrix technology. Elements of the MRM Matrix is available in the EireneRx, MedWise, TruChart, PACElogic and PrescribeWellness platforms.
Tricida is a pharmaceutical company focused on the development and commercialization of its drug candidate, TRC101 (veverimer), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal tract.
Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.
Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.
InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.